•
Dec 31, 2020

Selecta Biosciences Q4 2020 Earnings Report

Total Revenue
$12M
Previous year: $6.65M
+79.6%
EPS
-$0.14
Previous year: -$0.28
-50.0%
Gross Profit
$12M
Previous year: $6.65M
+79.6%
Cash and Equivalents
$139M
Previous year: $89.9M
+54.3%
Free Cash Flow
-$7.44M
Previous year: -$12.9M
-42.4%
Total Assets
$165M
Previous year: $99.6M
+66.2%

Selecta Biosciences

Selecta Biosciences